Clinical trial
Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening…
NCT00325741 · Stanford University, Other · Terminated
Key facts
| NCT number | NCT00325741 |
|---|---|
| Title | Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus |
| Official title | Allogeneic Hematopoietic Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus Using a Non-Myeloablative Regimen of Total Lymphoid Irradiation and Anti-Thymocyte Globulin |
| Acronym | SLE |
| Lead sponsor | Stanford University, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH City of Hope National Medical Center |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lupus Erythematosus, Systemic |
| Intervention type | Drug |
| Interventions | Hematopoietic Cell Transplantation |
| Enrollment | 1 |
| Start date | Jun 1, 2004 |
| Primary completion | Oct 1, 2015 |
| Completion | Oct 1, 2015 |
| First posted | May 15, 2006 |
| Last update posted | Aug 15, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: